Intranasal Vasopressin Treatment in Children With Autism

NCT03204786 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Autism
Autism Spectrum Disorder
ASD

Interventions

DRUG: Vasopressin (USP) Injectable Solution [Vasostrict]
DRUG: Placebo

Sponsor

Stanford University

Collaborators

[object Object]